These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2333977

  • 21. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
    Lignon MF, Galas MC, Rodriguez M, Laur J, Aumelas A, Martinez J.
    J Biol Chem; 1987 May 25; 262(15):7226-31. PubMed ID: 2438274
    [Abstract] [Full Text] [Related]

  • 22. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
    von Schrenck T, Moran TH, Heinz-Erian P, Gardner JD, Jensen RT.
    Am J Physiol; 1988 Oct 25; 255(4 Pt 1):G512-21. PubMed ID: 3177648
    [Abstract] [Full Text] [Related]

  • 23. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R, Bergeron F, Marseigne I, Durieux C, Roques BP.
    J Med Chem; 1990 Dec 25; 33(12):3199-204. PubMed ID: 1701834
    [Abstract] [Full Text] [Related]

  • 24. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig.
    Morini G, Barocelli E, Impicciatore M, Grider JR, Makhlouf GM.
    Regul Pept; 1990 May 21; 28(3):313-21. PubMed ID: 2377745
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH, Huang SC, Wank SA, Mantey S, Gardner JD, Jensen RT.
    Am J Physiol; 1990 Jan 21; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
    Smith AJ, McKernan RM.
    Br J Pharmacol; 1999 Jan 21; 126(1):79-86. PubMed ID: 10051123
    [Abstract] [Full Text] [Related]

  • 34. Biological effects of newly synthesized cholecystokinin analogs.
    Verspohl EJ, LaMura M.
    Horm Res; 2000 Jan 21; 53(4):177-84. PubMed ID: 11044801
    [Abstract] [Full Text] [Related]

  • 35. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM.
    J Med Chem; 1992 May 29; 35(11):2007-14. PubMed ID: 1375964
    [Abstract] [Full Text] [Related]

  • 36. Characterization of cholecystokinin receptors on the sphincter of Oddi.
    Cox KL, von Schrenck T, Moran TH, Gardner JD, Jensen RT.
    Am J Physiol; 1990 Nov 29; 259(5 Pt 1):G873-81. PubMed ID: 2240227
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.